FinanceCity
HealthcareNSE · BSE

Torrent Pharmaceuticals Ltd.

TORNTPHARM · ISIN INE685A01028

Share price

₹4,463 -0.92%

Market capitalisation

₹1.51L CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹1.51L Cr

Current price

₹4,463

-0.92% today

52W high

₹4,713

52W low

₹3,140

Stock P/E

69.77

P/B ratio

17.89

02 · Per share & returns

EPS (TTM)

₹63.96

Book value

₹249

ROE

16.99%

ROA

7.25%

Dividend yield

0.84%

Beta

0.15

03 · Financials (TTM)

By the numbers

Revenue

₹13980 Cr

+41.80% YoY

EBITDA

₹4497 Cr

Net profit

₹2163 Cr

-21.70% YoY

Profit margin

15.47%

Operating margin

20.20%

Total debt

₹15025 Cr

Total cash

₹2355 Cr

Debt / equity

0.85x

Current ratio

1.13x

Payout ratio

54.76%

04 · Analyst view

Target price

₹4,879

Upside

+9.33%

Consensus

NONE

Analysts

28

05 · Shareholding pattern

Who owns TORNTPHARM?

  • Promoters

    68.31%

    Founders & promoter group

  • Institutions

    15.69%

    FII + DII

  • Public

    16.00%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
TORNTPHARM
Exchange
NSE · BSE
CIN
ISIN
INE685A01028
BSE code
500420
Sector
Healthcare
Industry
Healthcare
Face value
₹5
Listing date
24 Nov 2002
Employees
18,258
Headquarters
Ahmedabad, India

07 · About

What is Torrent Pharmaceuticals Ltd.?

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

08 · Common questions

Frequently asked

What is the CIN of Torrent Pharmaceuticals Ltd.?+

The Corporate Identity Number for Torrent Pharmaceuticals Ltd. is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Torrent Pharmaceuticals Ltd.?+

Promoter holding in TORNTPHARM is approximately 68.31%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Torrent Pharmaceuticals Ltd.?+

Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a market capitalisation of approximately ₹1.51L Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →